Загрузка...
Regulatory Considerations for Biosimilars
Currently there is considerable interest in the legislative debate around generic biological drugs or “biosimilars” in the EU and US due to the large, lucrative market that it offers to the industry. While some countries have issued a few regulatory guidelines as well as product specific requirement...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Medknow Publications
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3149401/ https://ncbi.nlm.nih.gov/pubmed/21829775 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|